Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: Japan

Daiwa ETF TOPIX-17 Pharmaceutical

+ Add to Watchlist

04318087:JP

20,674.00 JPY 84.00 0.40%

As of 17:59:30 ET on 04/17/2015.

Snapshot for Daiwa ETF TOPIX-17 Pharmaceutical (04318087)

Year To Date: +22.36% 3-Month: +18.29% 3-Year: +30.79% 52-Week Range: 13,717.00 - 21,583.00
1-Month: +0.14% 1-Year: +50.43% 5-Year: +16.56% Beta vs TP17PHRM: 1.00

Mutual Fund Chart for 04318087

No chart data available.
  • 04318087:JP 20,674.00
  • 1M
  • 1Y
Interactive 04318087 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for 04318087

Daiwa ETF TOPIX-17 PHARMACEUTICAL ETF is an exchange-traded fund incorporated i n Japan. The objective of the Fund is to provide investment results that c orrespond to the performance of the TOPIX-17 Pharmaceutical Index.

Inception Date: 07-22-2008 Telephone: -
Managers: -
Web Site: www.daiwa-am.co.jp

Fundamentals for 04318087

NAV (on 2015-04-17) 20,674.00
Assets (M) (on 2015-04-17) 584.00
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for 04318087

Dividend Type Distribution
Dividend Frequency Semi-Anl
Last Dividend Net (on 2014-07-16) 181.00
Dividend Yield (ttm) 0.88

Fees & Expenses for 04318087

Front Load -
Back Load -
Current Mgmt Fee 0.18
Redemption Fee -
12b1 Fee -
Expense Ratio -

Top Fund Holdings for 04318087

Filing Date: 02/27/2015
Name Position Value % of Total
Takeda Pharmaceutical Co Ltd 20,100 123,072,300 22.541%
Astellas Pharma Inc 61,000 115,961,000 21.238%
Eisai Co Ltd 7,100 44,318,200 8.117%
Otsuka Holdings Co Ltd 10,600 37,995,700 6.959%
Daiichi Sankyo Co Ltd 18,000 33,696,000 6.171%
Shionogi & Co Ltd 8,400 29,526,000 5.408%
Ono Pharmaceutical Co Ltd 2,400 28,560,000 5.231%
Chugai Pharmaceutical Co Ltd 5,300 19,318,500 3.538%
Santen Pharmaceutical Co Ltd 10,000 16,020,000 2.934%
Mitsubishi Tanabe Pharma Corp 6,200 12,486,800 2.287%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil